P
Protagonist Therapeutics, Inc. (PTGX)
NGM – Real vaqt narxi. Valyuta: USD
99.95
-3.55 (-3.43%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
99.95
-3.55 (-3.43%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Protagonist Therapeutics, Inc. Qo'shma Shtatlarda kashfiyot va ishlab chiqish kompaniyasi sifatida faoliyat yuritadi. U kattalar va 12 yosh va undan katta bolalarda o'rtacha va og'ir darajadagi blyashka psoriazini davolash uchun birinchi o'rindagi tadqiqotiy og'iz orqali qabul qilinadigan peptid Icotyde; va kam uchraydigan qon kasalligi polisitemiya verani davolash uchun 3-bosqichli rivojlanishda bo'lgan tabiiy gormon gepsidinning birinchi o'rindagi tadqiqotiy in'ektsion mimeti Rusfertideni ishlab chiqadi. Kompaniya shuningdek, immunitet vositali teri kasalliklarini davolash uchun 1-bosqich klinik sinovlarida bo'lgan, potentsial eng yaxshi og'iz orqali qabul qilinadigan peptid IL-17 antagonist PN-881; semizlikni davolash uchun ishlab chiqish nomzodlari bo'lgan PN-477 va PN-458; og'iz orqali yuboriladigan gepsidin funksional mimeti kichik molekula PN-8047; atopik dermatit va o'rtacha va og'ir astmani davolash uchun L-4R alfa antagonist; va semizlikni davolash uchun amilin asosidagi og'iz orqali va teri osti mono- va poligonistlarini ishlab chiqmoqda. Protagonist Therapeutics, Inc. 2006 yilda ro'yxatga olingan va Kaliforniyaning Newark shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Arturo M. Molina FACP, M.D., M.S. | Chief Medical Officer |
| Dr. Ashok Bhandari Ph.D. | EVP & Chief Discovery Officer |
| Dr. Dinesh V. Patel Ph.D. | CEO, President, Secretary & Director |
| Dr. Newman Yeilding M.D. | Executive VP, Chief Scientific Officer |
| Mr. Asif Ali | Executive VP & CFO |
| Mr. Carter J. King | Executive Vice President of Business Development |
| Mr. Matthew M. Gosling J.D. | Executive VP and Chief Legal & Business Officer |
| Mr. Venkat Thalladi Ph.D. | EVP & Chief Technical Officer |
| Ms. Abha Bommireddi | Executive VP & Chief of Staff |
| Ms. Carena Spivey | Executive VP & Chief Human Resources Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-05 | 10-Q | ptgx-20260331x10q.htm |
| 2026-04-28 | DEFA14A | tm261434d3_defa14a.htm |
| 2026-04-28 | DEF 14A | tm261434-1_def14a.htm |
| 2026-02-25 | 10-K | ptgx-20251231x10k.htm |
| 2026-01-12 | 8-K | tm262863d1_8k.htm |
| 2025-11-06 | 8-K | tm2530353d1_8k.htm |
| 2025-11-06 | 10-Q | ptgx-20250930x10q.htm |
| 2025-08-06 | S-3ASR | tm2522559-1_s3asr.htm |
| 2025-08-06 | 10-Q | ptgx-20250630x10q.htm |
| 2025-06-26 | 8-K | tm2518863d1_8k.htm |